Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xencor Inc (NASDAQ:XNCR)

10.71
Delayed Data
As of Feb 05
 +0.17 / +1.61%
Today’s Change
10.19
Today|||52-Week Range
24.82
-26.74%
Year-to-Date
No recent news for Xencor Inc.

Today’s Trading

Previous close10.54
Today’s open10.45
Day’s range10.32 - 10.91
Volume344,874
Average volume (3 months)331,534
Market cap$433.5M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+86.49%
Earnings growth (this year)-84.13%
Earnings growth (next 5 years)--
Revenue growth (last year)-6.41%
P/E ratioNM
Price/Sales52.89
Price/Book5.68

Competitors

 Today’s
change
Today’s
% change
ACRSAclaris Therapeutics...-0.43-1.96%
SCLNSciClone Pharmaceuti...+0.65+8.01%
ENTAEnanta Pharmaceutica...-1.21-5.05%
COLLCollegium Pharmaceut...-0.52-2.70%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 18, 2016
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$9.5M
Annual profit (last year)-$16.4M
Net profit margin-172.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bassil I. Dahiyat
Vice President-Finance &
Investor Relations
John J. Kuch
Corporate headquarters
Monrovia, California

Forecasts

Partner Offers